Solutions For RealSolutions For Real
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

5 Things To Ask Aging Parents About Emergency Evacuations

June 21, 2025

A 16-Billion Password Leak Just Hit. Are You at Risk?

June 21, 2025

30 Best Stay-at-Home Jobs for Moms and Dads

June 21, 2025
Facebook Twitter Instagram
Trending
  • 5 Things To Ask Aging Parents About Emergency Evacuations
  • A 16-Billion Password Leak Just Hit. Are You at Risk?
  • 30 Best Stay-at-Home Jobs for Moms and Dads
  • Americans face vastly different retirement costs across states as Social Security cuts loom
  • The Best Defense Against Uncertainty Isn’t a Single Strategy — It’s a Mindset
  • Highly Profitable Corporations Amass Trillions In Cash And Pay Out Trillions In Dividends
  • Here’s What Will Happen When Social Security and Medicare Funds Run Dry
  • 10 Recession-Proof Jobs That Can Withstand a Downturn
Saturday, June 21
Facebook Twitter Instagram
Solutions For RealSolutions For Real
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
Solutions For RealSolutions For Real
Home » Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%
News

Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%

News RoomBy News RoomAugust 8, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

Eli Lilly on Tuesday raised its full-year guidance as second-quarter profit jumped 85% from the same period a year ago on strong sales from the pharmaceutical giant’s drug pipeline.

The company now expects full-year revenue of between $33.4 billion to $33.9 billion, up from a previous forecast of $31.2 billion to $31.7 billion. Eli Lilly also increased its adjusted earnings guidance to a range of $9.70 to $9.90 per share for the year, up from a range of $8.65 to $8.85.

Shares of Eli Lilly jumped 10% in premarket trading Tuesday.

Here’s how Eli Lilly performed, compared with Wall Street expectations, based on a survey of analysts by Refinitiv:

  • Adjusted earnings: $2.11 per share, vs. $1.98 per share expected
  • Revenue: $8.31 billion, vs. $7.58 billion expected

The company booked net income of $1.76 billion, or $1.95 per share, for the quarter. That’s up from net income of $952.5 million, or $1.05 per share, for the same period a year ago. 

Accounting for charges associated with some intangible assets and losses on securities, the company recorded adjusted income of $1.9 billion, or $2.11 per share.

The company’s $8.31 billion in sales for the quarter marked a 28% increase from the same period a year ago. 

That revenue growth was driven by sales of breast cancer pill Verzenio, which rose 57% to $926.8 million for the quarter.

Newer drugs like Mounjaro, the company’s Type 2 diabetes injection, also fueled revenue growth, posting $979.7 million in sales for the quarter. The drug was first approved in the U.S. in May 2022 and notched just $16 million in sales in the year-ago period. 

Eli Lilly said it “has experienced and continues to expect intermittent delays fulfilling orders of certain Mounjaro doses given significant demand.”

Eli Lilly also sold the rights to its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals in April, which brought in $579 million to the topline.

Eli Lilly’s stock has been on a tear in recent months, driven in part by positive trial results for its Alzheimer’s drug, donanemab, and the company’s progress with its promising obesity drug pipeline. 

Shares of Eli Lilly are up more than 24% for the year. With a market value of roughly $431 billion, Eli Lilly is the second-largest pharmaceutical company based in the U.S. after Johnson & Johnson.

Eli Lilly will hold a conference call with investors at 9:00 am ET. 

Executives will likely share updates on the company’s upcoming pipeline launches and recent acquisitions. That includes Eli Lilly’s $1.93 billion acquisition of Versanis, a privately held obesity drug maker. 

Executives are also likely to be asked about a lawsuit filed Monday by Nektar Therapeutics accusing Eli Lilly of undermining a drug development deal established between the two companies in 2017.

This story is developing. Please check back for updates.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Lucid shares tumble following public offering of nearly 262.5 million shares

News October 17, 2024

Harris distances herself from Biden, bashes Trump in tense Fox News interview

News October 17, 2024

Alibaba’s international arm says its new AI translation tool beats Google and ChatGPT

News October 16, 2024

I bought a $54,000 abandoned house in Japan and turned it into a luxury Airbnb—take a look inside

News October 16, 2024

Trump’s crypto coin goes on sale with Election Day just three weeks out

News October 15, 2024

Cramer’s Lightning Round: Uranium Energy is ‘the real deal’

News October 15, 2024
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

A 16-Billion Password Leak Just Hit. Are You at Risk?

June 21, 20250 Views

30 Best Stay-at-Home Jobs for Moms and Dads

June 21, 20250 Views

Americans face vastly different retirement costs across states as Social Security cuts loom

June 21, 20250 Views

The Best Defense Against Uncertainty Isn’t a Single Strategy — It’s a Mindset

June 21, 20250 Views
Don't Miss

Highly Profitable Corporations Amass Trillions In Cash And Pay Out Trillions In Dividends

By News RoomJune 20, 2025

Nonfinancial corporations continue to do very well. Recent data from the Federal Reserve, specifically its…

Here’s What Will Happen When Social Security and Medicare Funds Run Dry

June 20, 2025

10 Recession-Proof Jobs That Can Withstand a Downturn

June 20, 2025

How Building Gaming Tech Led Us to a Business Breakthrough

June 20, 2025
About Us
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

5 Things To Ask Aging Parents About Emergency Evacuations

June 21, 2025

A 16-Billion Password Leak Just Hit. Are You at Risk?

June 21, 2025

30 Best Stay-at-Home Jobs for Moms and Dads

June 21, 2025
Most Popular

15 Best Paid Survey Sites For Kids

December 12, 20231 Views

5 Things To Ask Aging Parents About Emergency Evacuations

June 21, 20250 Views

A 16-Billion Password Leak Just Hit. Are You at Risk?

June 21, 20250 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Solutions For Real. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.